330 related articles for article (PubMed ID: 36788228)
1. Single-cell sequencing of ascites fluid illustrates heterogeneity and therapy-induced evolution during gastric cancer peritoneal metastasis.
Huang XZ; Pang MJ; Li JY; Chen HY; Sun JX; Song YX; Ni HJ; Ye SY; Bai S; Li TH; Wang XY; Lu JY; Yang JJ; Sun X; Mills JC; Miao ZF; Wang ZN
Nat Commun; 2023 Feb; 14(1):822. PubMed ID: 36788228
[TBL] [Abstract][Full Text] [Related]
2. Malignant ascites-derived exosomes promote peritoneal tumor cell dissemination and reveal a distinct miRNA signature in advanced gastric cancer.
Hu Y; Qi C; Liu X; Zhang C; Gao J; Wu Y; Yang J; Zhao Q; Li J; Wang X; Shen L
Cancer Lett; 2019 Aug; 457():142-150. PubMed ID: 31075288
[TBL] [Abstract][Full Text] [Related]
3. Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites.
Lim B; Kim C; Kim JH; Kwon WS; Lee WS; Kim JM; Park JY; Kim HS; Park KH; Kim TS; Park JL; Chung HC; Rha SY; Kim SY
Oncotarget; 2016 Feb; 7(7):8055-66. PubMed ID: 26811494
[TBL] [Abstract][Full Text] [Related]
4. Gastric cancer peritoneal metastasis related signature predicts prognosis and sensitivity to immunotherapy in gastric cancer.
Sun Y; Chen Y; Zhuang W; Fang S; Chen Q; Lian M; Lv C; Weng J; Wei R; Lin Y; Cai L; Wang Q
J Cell Mol Med; 2023 Nov; 27(22):3578-3590. PubMed ID: 37605453
[TBL] [Abstract][Full Text] [Related]
5. MiR-136 inhibits gastric cancer-specific peritoneal metastasis by targeting HOXC10.
Zheng J; Ge P; Liu X; Wei J; Wu G; Li X
Tumour Biol; 2017 Jun; 39(6):1010428317706207. PubMed ID: 28656883
[TBL] [Abstract][Full Text] [Related]
6. Tumor-promoting macrophages prevail in malignant ascites of advanced gastric cancer.
Eum HH; Kwon M; Ryu D; Jo A; Chung W; Kim N; Hong Y; Son DS; Kim ST; Lee J; Lee HO; Park WY
Exp Mol Med; 2020 Dec; 52(12):1976-1988. PubMed ID: 33277616
[TBL] [Abstract][Full Text] [Related]
7. Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer.
Tokuhisa M; Ichikawa Y; Kosaka N; Ochiya T; Yashiro M; Hirakawa K; Kosaka T; Makino H; Akiyama H; Kunisaki C; Endo I
PLoS One; 2015; 10(7):e0130472. PubMed ID: 26208314
[TBL] [Abstract][Full Text] [Related]
8. Differential gene expression profiles of gastric cancer cells established from primary tumour and malignant ascites.
Sakakura C; Hagiwara A; Nakanishi M; Shimomura K; Takagi T; Yasuoka R; Fujita Y; Abe T; Ichikawa Y; Takahashi S; Ishikawa T; Nishizuka I; Morita T; Shimada H; Okazaki Y; Hayashizaki Y; Yamagishi H
Br J Cancer; 2002 Nov; 87(10):1153-61. PubMed ID: 12402156
[TBL] [Abstract][Full Text] [Related]
9. Integration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis.
Gwee YX; Chia DKA; So J; Ceelen W; Yong WP; Tan P; Ong CJ; Sundar R
J Clin Oncol; 2022 Aug; 40(24):2830. PubMed ID: 35649219
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of crucial lnc-TRIM28-14 and hub genes promoting gastric cancer peritoneal metastasis.
Dong C; Luan F; Tian W; Duan K; Chen T; Ren J; Li W; Li D; Zhi Q; Zhou J
BMC Cancer; 2023 Jan; 23(1):76. PubMed ID: 36690975
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-autophagy axis induces VEGFA by peritoneal mesothelial cells to promote gastric cancer peritoneal metastasis through an integrin α5-fibronectin pathway.
Wang X; Che X; Yu Y; Cheng Y; Bai M; Yang Z; Guo Q; Xie X; Li D; Guo M; Hou K; Guo W; Qu X; Cao L
J Exp Clin Cancer Res; 2020 Oct; 39(1):221. PubMed ID: 33081836
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant Intraperitoneal and Systemic Chemotherapy Versus Neoadjuvant Systemic Chemotherapy With Docetaxel, Oxaliplatin, and S-1 for Gastric Cancer With Peritoneal Metastasis: A Propensity Score Matched Analysis.
Zhang X; Huang H; Yang D; Wang P; Huang X; Hu Z; Zhang Y; Yan R; Zhu Z; Cai Q
Technol Cancer Res Treat; 2021; 20():15330338211036310. PubMed ID: 34328799
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: A single-center retrospective analysis of 125 patients.
Ji ZH; Yu Y; Liu G; Zhang YB; An SL; Li B; Li XB; Yan GJ; Li Y
Eur J Surg Oncol; 2021 Jun; 47(6):1411-1419. PubMed ID: 33293213
[TBL] [Abstract][Full Text] [Related]
14. Development of the oncolytic virus, CF33, and its derivatives for peritoneal-directed treatment of gastric cancer peritoneal metastases.
Yang A; Zhang Z; Chaurasiya S; Park AK; Jung A; Lu J; Kim SI; Priceman S; Fong Y; Woo Y
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37019471
[TBL] [Abstract][Full Text] [Related]
15. Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis.
Okugawa Y; Toiyama Y; Hur K; Toden S; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Kusunoki M; Boland CR; Goel A
Carcinogenesis; 2014 Dec; 35(12):2731-9. PubMed ID: 25280565
[TBL] [Abstract][Full Text] [Related]
16. Specific lineage transition of tumor-associated macrophages elicits immune evasion of ascitic tumor cells in gastric cancer with peritoneal metastasis.
Li Y; Jiang L; Chen Y; Li Y; Yuan J; Lu J; Zhang Z; Liu S; Feng X; Xiong J; Jiang Y; Zhang X; Li J; Shen L
Gastric Cancer; 2024 May; 27(3):519-538. PubMed ID: 38460015
[TBL] [Abstract][Full Text] [Related]
17. Soluble factors in malignant ascites promote the metastatic adhesion of gastric adenocarcinoma cells.
Al-Marzouki L; Stavrakos VS; Pal S; Giannias B; Bourdeau F; Rayes R; Bertos N; Najmeh S; Spicer JD; Cools-Lartigue J; Bailey SD; Ferri L; Sangwan V
Gastric Cancer; 2023 Jan; 26(1):55-68. PubMed ID: 36059037
[TBL] [Abstract][Full Text] [Related]
18. SPHK1-induced autophagy in peritoneal mesothelial cell enhances gastric cancer peritoneal dissemination.
Yin S; Miao Z; Tan Y; Wang P; Xu X; Zhang C; Hou W; Huang J; Xu H
Cancer Med; 2019 Apr; 8(4):1731-1743. PubMed ID: 30791228
[TBL] [Abstract][Full Text] [Related]
19. REG4 promotes peritoneal metastasis of gastric cancer through GPR37.
Wang H; Hu L; Zang M; Zhang B; Duan Y; Fan Z; Li J; Su L; Yan M; Zhu Z; Liu B; Yang Q
Oncotarget; 2016 May; 7(19):27874-88. PubMed ID: 27036049
[TBL] [Abstract][Full Text] [Related]
20. Nuclear heat shock protein 110 expression is associated with poor prognosis and hyperthermo-chemotherapy resistance in gastric cancer patients with peritoneal metastasis.
Kimura A; Ogata K; Altan B; Yokobori T; Mochiki E; Yanai M; Kogure N; Yanoma T; Suzuki M; Bai T; Kuwano H
World J Gastroenterol; 2017 Nov; 23(42):7541-7550. PubMed ID: 29204054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
